))
Ep. 52 - Khoo Shih on Scaling Singapore Biotech
Manage episode 416005602 series 3571902
Sisällön tarjoaa BioCentury. BioCentury tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.
Success for the Singapore biotech project will take a global network, one which Khoo Shih and other prominent drivers of the local ecosystem are keen to leverage to bring the right combination of talent, experience and capital to the growing hub. Speaking on The BioCentury Show, Khoo Shih, CEO of investment firm ClavystBio, laid out the strategy for capitalizing on the ascendant energy and attention being devoted to Singapore biotech. While the goal continues to be to create companies that solve global problems and have a global outreach, she said the path involves bringing in international life science investors from day one.
View full story: https://www.biocentury.com/article/651376
#biotech #biopharma #pharma #TheBioCenturyShow
00:00 – Intro
04:48 – ClavystBio
08:18 – Why Singapore
19:07 – 65Labs Incubator
23:20 – Growing the Ecosystem
Luvut
1. Introduction (00:00:00)
2. ClavystBio (00:04:48)
3. Why Singapore (00:08:18)
4. 65Labs Incubator (00:19:07)
5. Growing the Ecosystem (00:23:20)
22 jaksoa
Jaa
